Point72 Hong Kong LTD Puma Biotechnology, Inc. Call Options Transaction History
Point72 Hong Kong LTD
- $1.34 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PBYI
# of Institutions
132Shares Held
34.1MCall Options Held
68.2KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.13MShares$20.9 Million9.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.69MShares$18.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$18.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.15MShares$10.9 Million0.02% of portfolio
-
Acadian Asset Management LLC Boston, MA2.05MShares$10.4 Million0.02% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $231M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...